8 While GLP-1 medications are highly effective tools, they are not a cure-all for the chronic condition of obesity
Current Coverage Statistics: Approximately 31% of Canadian employers now provide coverage for GLP-1 medications for both diabetes and weight loss applications However, 56% of employers still limit coverage to diabetes-only use Fewer than 20% of private drug plans cover anti-obesity medications at all What to Expect with Private Coverage: If your private insurance includes semaglutide, most plans cover 50-80% of the medication cost, with co-payments typically ranging from $106 to several hundred dollars monthly
If shedding has already begun, these same approaches will support faster recovery
La comunicacin transparente sobre lmites, tiempos de retiro y verificacin anticipada evita la frustracin
It should only be used in authorised clinical trials
The dose can be gradually increased to 5 mg per week, depending on personal goals and the advice of a healthcare professional